A detailed history of New Capital Management LP transactions in Abb Vie Inc. stock. As of the latest transaction made, New Capital Management LP holds 3,000 shares of ABBV stock, worth $549,240. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,000
Previous 3,000 -0.0%
Holding current value
$549,240
Previous $514,000 15.18%
% of portfolio
0.18%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024

SELL
$137.6 - $154.97 $206,400 - $232,455
-1,500 Reduced 33.33%
3,000 $464,000
Q2 2022

Jul 08, 2022

SELL
$137.62 - $174.96 $31,377 - $39,890
-228 Reduced 4.82%
4,500 $684,000
Q1 2022

Apr 08, 2022

BUY
$131.98 - $163.75 $624,001 - $774,210
4,728 New
4,728 $766,000
Q1 2018

Apr 12, 2018

SELL
$92.01 - $123.21 $13,893 - $18,604
-151 Closed
0 $0
Q3 2017

Oct 23, 2017

BUY
$69.85 - $89.22 $10,547 - $13,472
151
151 $13,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track New Capital Management LP Portfolio

Follow New Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on New Capital Management LP with notifications on news.